General Information
Version
10.0
Revision date
2024-09-30
Product name
Cefazolin Sodium, Ancef for Injection
Chemical name
5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-{[(5-methyl-1,3,4-thiadiazol-2-y])thio]-methyl} -8-0xo0-7- [[(1H-tetrazol-1-yl)acetyl]Jamino]-, monosodium salt (6R- trans)
CAS No.
27164-46-1
1.2.1 Relevant identified uses
Antibiotic
Icons in SDS
Company Information
company name
Sagent Pharmaceuticals
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
OSHA (a) Classification
Hazard categories
Category 1 Category 2 Category 1
Hazard pictograms
@ C
Signal word
Danger ‘Warning
Hazard statements
May cause allergy May cause damage May cause an or asthma symptoms to the allergic skin or breathing gastrointestinal reaction. difficulties if system, liver, inhaled. kidneys, blood, and skin through prolonged or repeated exposure.
Precautionary statements
Avoid breathing dust/fume/gas/mist/vapors/spray. In case of inadequate ventilation wear respiratory protection. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves. IF ON SKIN: Wash with plenty of soap and water. If skin irritation or rash occurs: Get medical advice/ attention. IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician (d) Unknown Acute Toxicity: N/A Previous Document No Confidential - For Use Only By Affiliates Page SDS002 of Sagent Pharmaceuticals Page 2 of 11 l
2.1 Classification of the substance or mixture
U.S. OSHA Classification Possible sensitizer Target Organ Toxin Previous Document No Confidential - For Use Only By Affiliates Page SDS002 of Sagent Pharmaceuticals Page 1of11 l (b) Signal Word, Hazard | (c) Description of Hazards
